目录
- Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21 st century
- Interplay between nuclear factor erythroid 2 -related factor 2 and inflammatory mediators in COVID-19 -related liver injury
- Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review
- Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer
- Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4 + CD25 + Foxp3 + regulatory T cells in the immune microenvironment
- Role of bile acids in liver diseases mediated by the gut microbiome
- Liver injury in COVID-19 : Detection, pathogenesis, and treatment
- Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma
- Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
- and pediatric fatty liver disease: Is there interplay?
- Enhancer of zeste homolog 2 contributes to apoptosis by inactivating janus kinase 2 / signal transducer and activator of transcription signaling in inflammatory bowel disease
- Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival
- Idiopathic mesenteric phlebosclerosis associated with long-term oral intake of geniposide
- Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
- Preservation of superior rectal artery in laparoscopically assisted subtotal colectomy with ileorectal anastomosis for slow transit constipation
- High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study
- Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression